Mid Continent Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$7.87M Sell
84,322
-709
-0.8% -$68.6K 0.51% 52
2015
Q2
$8.29M Sell
85,031
-2,298
-3% -$230K 0.46% 60
2015
Q1
$8.79M Sell
87,329
-2,608
-3% -$265K 0.48% 58
2014
Q4
$9.4M Buy
89,937
+317
+0.4% +$33.4K 0.54% 51
2014
Q3
$9.55M Buy
89,620
+565
+0.6% +$58.6K 0.56% 50
2014
Q2
$9.32M Buy
89,055
+1,995
+2% +$202K 0.54% 53
2014
Q1
$8.55M Buy
87,060
+3,958
+5% +$367K 0.51% 57
2013
Q4
$7.61M Buy
83,102
+14,445
+21% +$1.33M 0.47% 62
2013
Q3
$5.95M Buy
68,657
+28,702
+72% +$2.57M 0.42% 66
2013
Q2
$3.43M Buy
+39,955
New +$3.39M 0.25% 84

Other funds holding JNJ

Mid Continent Capital's JNJ Position: Q3 2015 in Review

Mid Continent Capital reduced its Johnson & Johnson (JNJ) stake by 0.83% in Q3 2015, selling an estimated $68.6K and leaving 84,322 shares worth $7.87M. The position accounts for 0.51% of the portfolio, ranked #52.

Mid Continent Capital first reported a position in JNJ in Q2 2013 and has held it in 10 quarters since. The position peaked at $9.55M in Q3 2014. 2,094 funds tracked by Wall St. Rank hold JNJ as of Q3 2015.

  • Mid Continent Capital held 84,322 shares of Johnson & Johnson worth $7.87M as of Q3 2015.
  • Mid Continent Capital sold 709 Johnson & Johnson shares in Q3 2015, an estimated $68.6K.
  • Johnson & Johnson made up 0.51% of Mid Continent Capital's portfolio in Q3 2015, its #52 holding.
  • Mid Continent Capital first reported a position in Johnson & Johnson in Q2 2013 and has held it in 10 quarters since.
  • Mid Continent Capital's Johnson & Johnson position peaked at $9.55M in Q3 2014.
  • 2,094 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2015.

Based on Mid Continent Capital's 13F filing for Q3 2015, filed 22 Oct 2015.